XML 78 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Income Taxes loss before income taxes consists of the following (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Domestic

 

$

(110,938

)

 

$

(40,587

)

 

$

(174,041

)

International

 

 

(27,374

)

 

 

(33,617

)

 

 

(18,887

)

Loss before income taxes

 

$

(138,312

)

 

$

(74,204

)

 

$

(192,928

)

Schedule of Significant Components of Provision for Income Taxes

Significant components of the Company's benefit (expense) from income taxes are as follows (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

 

 

$

 

State

 

 

(233

)

 

 

(197

)

 

 

(87

)

Foreign

 

 

(103

)

 

 

(373

)

 

 

(405

)

Total current tax expense

 

 

(336

)

 

 

(570

)

 

 

(492

)

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

 

 

 

 

 

 

 

State

 

 

 

 

 

 

 

 

 

Foreign

 

 

(237

)

 

 

118

 

 

 

3,322

 

Total deferred benefit

 

 

(237

)

 

 

118

 

 

 

3,322

 

Total benefit (expense) from income taxes

 

$

(573

)

 

$

(452

)

 

$

2,830

 

 

Schedule of Reconciliation of Income Taxes at Statutory Rate to (Provision for)/Benefit (expense) from Income Taxes Recorded in Statements of Operations

Reconciliation of income taxes at the statutory rate to the benefit (expense) from income taxes recorded in the statements of operations is as follows:

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Tax benefit at federal statutory rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

State tax expense, net of federal benefit

 

 

2.4

 

 

 

1.3

 

 

 

0.8

 

Foreign tax expense

 

 

0.0

 

 

 

8.1

 

 

 

0.8

 

Change in valuation allowance

 

 

(8.2

)

 

 

(21.9

)

 

 

17.1

 

Federal R&D credit

 

 

0.8

 

 

 

0.2

 

 

 

0.2

 

Unrecognized tax benefit

 

 

1.0

 

 

 

 

 

 

0.9

 

Non-deductible interest/premium

 

 

 

 

 

 

 

 

(0.3

)

Bargain purchase gain

 

 

3.8

 

 

 

 

 

 

 

Non-deductible loss on Forward Sale of Preferred Stock and Bridge Loans

 

 

 

 

 

 

 

 

(8.0

)

R&D tax credits expiring unutilized

 

 

(11.5

)

 

 

 

 

 

(5.2

)

NOL carryforwards expiring unutilized

 

 

(4.1

)

 

 

(5.5

)

 

 

(22.8

)

Transaction costs

 

 

(1.6

)

 

 

(1.5

)

 

 

 

Executive stock-based compensation

 

 

(2.3

)

 

 

(2.6

)

 

 

(0.8

)

Return to provision

 

 

(0.5

)

 

 

2.5

 

 

 

 

Other, net

 

 

(1.2

)

 

 

(2.0

)

 

 

(2.2

)

Effective tax rate

 

 

(0.4

)%

 

 

(0.4

)%

 

 

1.5

%

Schedule of Significant Components of Deferred Tax Assets and Liabilities

Significant components of the Company's deferred tax assets and liabilities are as follows (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforward

 

$

242,050

 

 

$

96,242

 

Reserves and accruals

 

 

14,672

 

 

 

3,152

 

Depreciation and amortization

 

 

3,354

 

 

 

564

 

Capitalized R&D costs

 

 

25,138

 

 

 

5,962

 

Tax credit carryforwards

 

 

17,216

 

 

 

15,463

 

Stock-based compensation

 

 

7,801

 

 

 

1,143

 

Right-of-use lease liabilities

 

 

7,749

 

 

 

7,782

 

Total gross deferred tax assets

 

 

317,980

 

 

 

130,308

 

Valuation allowance on deferred tax assets

 

 

(304,382

)

 

 

(124,124

)

Total deferred tax assets, net of valuation allowance

 

 

13,598

 

 

 

6,184

 

Deferred tax liabilities:

 

 

 

 

 

 

Fixed assets and intangibles

 

 

(7,740

)

 

 

(54

)

Right-of-use assets

 

 

(6,801

)

 

 

(6,836

)

Total deferred tax liabilities

 

 

(14,541

)

 

 

(6,890

)

Net deferred tax liability

 

$

(943

)

 

$

(706

)

 

 

 

 

 

 

 

Deferred tax liability per balance sheet

 

$

(1,081

)

 

$

(841

)

Less deferred tax assets included in other long-term assets

 

 

138

 

 

 

135

 

Net deferred tax liability

 

$

(943

)

 

$

(706

)

Schedule of Summary of Valuation Allowance

A reconciliation of the beginning and ending amounts of the valuation allowance for the years ended December 31, 2024, 2023 and 2022, is as follows (in thousands):

 

 

Valuation Allowance

 

December 31, 2021

 

$

141,087

 

Charges to earnings

 

 

 

Charges to other accounts

 

 

(33,194

)

December 31, 2022

 

 

107,893

 

Charges to earnings

 

 

 

Charges to other accounts

 

 

16,231

 

December 31, 2023

 

 

124,124

 

Charges to earnings

 

 

 

Charges to other accounts

 

 

180,258

 

December 31, 2024

 

$

304,382

 

Schedule of Aggregate Changes in Balance of Gross Unrecognized Tax Benefits

The aggregate changes in the balance of the Company's gross unrecognized tax benefits during 2024, 2023, and 2022, were as follows (in thousands):

 

December 31, 2021

 

$

8,515

 

Increases in balances related to tax positions during a prior
   period

 

 

154

 

Increases in balances related to tax positions taken during current
   period

 

 

 

Decreases in balances related to tax positions during a prior
   period

 

 

(1,697

)

December 31, 2022

 

 

6,972

 

Increases in balances related to tax positions during a prior
   period

 

 

105

 

Decreases in balances related to tax positions taken during current
   period

 

 

(138

)

December 31, 2023

 

 

6,939

 

Increases in balances related to tax positions during a prior
   period

 

 

 

Increases in balances related to tax positions taken during
   current period

 

 

2,682

 

Decreases in balances related to tax positions during a prior
   period

 

 

(357

)

December 31, 2024

 

$

9,264